Up 1.4% to $51.70, Illumina (NASDAQ:ILMN), is one of today's notable movers. The S&P is currently trading fractionally lower to 1,509 and the Dow Jones Industrial Average is trading 0.2% lower to 13,945.
In the past 52 weeks, shares of Illumina have traded between a low of $25.57 and a high of $79.40 and are now at $51.70, which is 102% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has remained constant.
There is potential upside of 6.1% for shares of Illumina based on a current price of $51.70 and an average consensus analyst price target of $54.88. The stock should find resistance at its 50-day moving average (MA) of $52.52, as well as support at its 200-day MA of $46.39.
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.